Global Patent Index - EP 1373222 A2

EP 1373222 A2 20040102 - 5-PHENYLPYRIMIDINE, METHODS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF AND USE OF THE SAME FOR CONTROLLING PATHOGENIC FUNGI

Title (en)

5-PHENYLPYRIMIDINE, METHODS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF AND USE OF THE SAME FOR CONTROLLING PATHOGENIC FUNGI

Title (de)

5-PHENYLPYRIMIDINE, VERFAHREN UND ZWISCHENPRODUKTE ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ZUR BEKAEMPFUNG VON SCHADPILZEN

Title (fr)

5-PHENYLPYRIMIDINES, PROCEDE ET PRODUITS INTERMEDIAIRES UTILISES POUR LES PRODUIRE ET LEUR UTILISATION POUR LUTTER CONTRE DES CHAMPIGNONS NUISIBLES

Publication

EP 1373222 A2 20040102 (DE)

Application

EP 02729999 A 20020313

Priority

  • DE 10112915 A 20010315
  • DE 10116432 A 20010402
  • EP 0202739 W 20020313

Abstract (en)

[origin: WO02074753A2] The invention relates to 5-phenylpyrimidine of formula I wherein the substituents have the following designations: R<1> represents a five to ten-membered saturated, partially unsaturated or aromatic monocyclic or bicyclic heterocycle which contains between one and four heteroatoms from the group 0, N or S, and which can be substituted as defined in the description; R<2> represents hydrogen, halogen, cyano, alkyl, halogenalkyl or alkoxy; R<3> and R<4> represent hydrogen, alkyl, halogenalkyl, cycloalkyl, halogencycloalkyl, alkenyl, halogenalkenyl, cycloalkenyl, alkinyl, halogenalkinyl or cycloalkinyl; together with the nitrogen atom to which they are bonded, R<3> and R<4> can also form a five or six-membered ring which can be split by a heteroatom and can carry at least one substituent; R<5> and R<6> represent hydrogen, halogen, alkyl, halogenalkyl or alkoxy; R<7> and R<8> represent hydrogen, halogen, alkyl or halogenalkyl; and R<9> represents hydrogen, halogen, alkyl, alkoxy, cycloalkoxy, halogenalkoxy or alkoxycarbonyl. The invention also relates to methods and intermediate products for producing said compounds and the use of the same for controlling pathogenic fungi.

[origin: WO02074753A2] The invention relates to 5-phenylpyrimidine of formula (I) wherein the substituents have the following designations: R<1> represents a five to ten-membered saturated, partially unsaturated or aromatic monocyclic or bicyclic heterocycle which contains between one and four heteroatoms from the group 0, N or S, and which can be substituted as defined in the description; R<2> represents hydrogen, halogen, cyano, alkyl, halogenalkyl or alkoxy; R<3> and R<4> represent hydrogen, alkyl, halogenalkyl, cycloalkyl, halogencycloalkyl, alkenyl, halogenalkenyl, cycloalkenyl, alkinyl, halogenalkinyl or cycloalkinyl; together with the nitrogen atom to which they are bonded, R<3> and R<4> can also form a five or six-membered ring which can be split by a heteroatom and can carry at least one substituent; R<5> and R<6> represent hydrogen, halogen, alkyl, halogenalkyl or alkoxy; R<7> and R<8> represent hydrogen, halogen, alkyl or halogenalkyl; and R<9> represents hydrogen, halogen, alkyl, alkoxy, cycloalkoxy, halogenalkoxy or alkoxycarbonyl. The invention also relates to methods and intermediate products for producing said compounds and the use of the same for controlling pathogenic fungi.

IPC 1-7

C07D 239/42; A01N 43/54; C07D 403/04; C07D 473/00; C07D 487/04

IPC 8 full level

A01N 43/54 (2006.01); A01N 43/56 (2006.01); A01N 43/58 (2006.01); A01N 43/60 (2006.01); A01N 43/64 (2006.01); A01N 43/647 (2006.01); A01N 43/653 (2006.01); A01N 43/713 (2006.01); A01N 43/90 (2006.01); C07D 239/42 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 471/04 (2006.01); C07D 473/06 (2006.01); C07D 487/04 (2006.01); C07D 521/00 (2006.01)

CPC (source: EP KR US)

A01N 43/54 (2013.01 - EP US); A01N 43/56 (2013.01 - EP US); A01N 43/60 (2013.01 - EP US); A01N 43/647 (2013.01 - EP US); A01N 43/653 (2013.01 - EP US); A01N 43/713 (2013.01 - EP US); A01N 43/90 (2013.01 - EP US); C07D 231/12 (2013.01 - EP US); C07D 233/56 (2013.01 - EP US); C07D 239/42 (2013.01 - EP US); C07D 249/08 (2013.01 - EP US); C07D 401/04 (2013.01 - KR); C07D 403/04 (2013.01 - EP US); C07D 473/06 (2013.01 - EP US); C07D 487/04 (2013.01 - EP US)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 02074753 A2 20020926; WO 02074753 A3 20021227; AU 2002302420 B2 20071206; BG 108174 A 20040930; BR 0207975 A 20040615; CA 2440405 A1 20020926; CN 100488952 C 20090520; CN 1525960 A 20040901; CZ 20032475 A3 20031217; EA 007719 B1 20061229; EA 200300931 A1 20040226; EE 200300448 A 20040216; EP 1373222 A2 20040102; HU P0400210 A2 20040830; HU P0400210 A3 20051128; IL 157723 A0 20040328; JP 2004525133 A 20040819; JP 4361736 B2 20091111; KR 100849311 B1 20080729; KR 20030082981 A 20031023; MX PA03008121 A 20031212; NZ 528409 A 20051125; PL 366463 A1 20050207; SK 11422003 A3 20040406; US 2004116429 A1 20040617; US 2007088026 A1 20070419; US 7153860 B2 20061226; US 7709637 B2 20100504

DOCDB simple family (application)

EP 0202739 W 20020313; AU 2002302420 A 20020313; BG 10817403 A 20030912; BR 0207975 A 20020313; CA 2440405 A 20020313; CN 02806579 A 20020313; CZ 20032475 A 20020313; EA 200300931 A 20020313; EE P200300448 A 20020313; EP 02729999 A 20020313; HU P0400210 A 20020313; IL 15772302 A 20020313; JP 2002573762 A 20020313; KR 20037011943 A 20030909; MX PA03008121 A 20020313; NZ 52840902 A 20020313; PL 36646302 A 20020313; SK 11422003 A 20020313; US 47153203 A 20030911; US 54886406 A 20061012